Skip to main content
. 2016 Feb 5;11(2):e0148076. doi: 10.1371/journal.pone.0148076

Table 1. Comorbidity distribution based on the age-adjusted Charlson comorbidities, n = 156,151.

Variable Point Number of patients (%)
Age
    40≧Age 0 11317(7.2)
    50≧Age>40 1 30094(19.3)
    60≧Age>50 2 41781(26.8)
    70≧Age>60 3 33897(21.7)
    80≧Age>70 4 27706(17.7)
        Age>80 4 11356(7.3)
Myocardial infarction 1 305(0.2)
Congestive heart failure 1 966(0.6)
Peripheral vascular disease 1 167(0.1)
Cerebrovascular disease 1 1726(1.1)
Dementia 1 193(0.1)
Chronic pulmonary disease 1 3143(2.0)
Rheumatic disease 1 220(0.1)
Peptic ulcer disease 1 6414(4.1)
Mild liver disease 1 5184(3.3)
Diabetes mellitus without end-organ damage 1 7775(5.0)
Diabetes mellitus with end-organ damage 2 732(0.5)
Hemiplegia 2 118(0.1)
Renal disease 2 1053(0.7)
Any malignancy* 2 10737(6.9)
Lymphoma 2 267(0.2)
Leukemia 2 95(0.1)
Moderate liver disease 3 846(0.5)
Metastatic solid tumor 6 6135(3.9)
Acquired immunodeficiency syndrome (AIDS) 6 2(0.0)

*Patients with more than one type of cancer in this study population.

Renal disease: chronic glomerulonephritis; nephritis and nephropathy; chronic renal failure.

Mild liver disease: chronic hepatitis; alcoholic cirrhosis; biliary cirrhosis. Moderate liver disease: liver diseases with cirrhosis-related complications.